CHAMPIONS ONCOLOGY, INC. Cash and Restricted Cash
CHAMPIONS ONCOLOGY, INC. (CSBR) had Cash and Restricted Cash of $4.36 million as of 2026-07-31, per its 10-Q filed 2026-09-11.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-09-11
- 2026-07-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $4.36M.
- 2026-04-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $4.87M.
- 2026-01-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $7.13M.
- 2025-10-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $8.52M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-07-31 | $4.36M 10-Q · filed 2026-09-11 |
| 2026-04-30 | $4.87M 10-Q · filed 2026-09-11 |
| 2026-01-31 | $7.13M 10-Q · filed 2026-03-12 |
| 2025-10-31 | $8.52M 10-Q · filed 2025-12-15 |
| 2025-07-31 | $10.32M 10-Q · filed 2026-09-11 |
| 2025-04-30 | $9.79M 10-Q · filed 2026-09-11 |
| 2025-01-31 | $3.20M 10-Q · filed 2026-03-12 |
| 2024-10-31 | $2.75M 10-Q · filed 2025-12-15 |
| 2024-07-31 | $2.89M 10-Q · filed 2025-09-15 |
| 2024-04-30 | $2.62M 10-K · filed 2026-07-27 |
| 2024-01-31 | $4.47M 10-Q · filed 2025-03-17 |
| 2023-10-31 | $5.51M 10-Q · filed 2024-12-16 |
| 2023-07-31 | $4.87M 10-Q · filed 2024-09-13 |
| 2023-04-30 | $10.12M 10-K · filed 2025-07-23 |
| 2023-01-31 | $11.64M 10-Q · filed 2024-03-15 |
| 2022-10-31 | $10.83M 10-Q · filed 2023-12-13 |
| 2022-07-31 | $8.06M 10-Q · filed 2023-09-13 |
| 2022-04-30 | $9.01M 10-K · filed 2024-07-19 |
| 2022-01-31 | $8.70M 10-Q · filed 2023-03-16 |
| 2021-10-31 | $4.78M 10-Q · filed 2022-12-13 |
| 2021-07-31 | $4.00M 10-Q · filed 2022-09-12 |
| 2021-04-30 | $4.69M 10-K · filed 2023-07-24 |
| 2021-01-31 | $7.43M 10-Q · filed 2022-03-15 |
| 2020-10-31 | $8.55M 10-Q · filed 2021-12-13 |
| 2020-07-31 | $6.94M 10-Q · filed 2021-09-13 |
| 2020-04-30 | $8.34M 10-K · filed 2022-07-22 |
| 2020-01-31 | $3.28M 10-Q · filed 2021-03-15 |
| 2019-10-31 | $2.78M 10-Q · filed 2020-12-14 |
| 2019-07-31 | $2.20M 10-Q · filed 2020-09-14 |
| 2019-04-30 | $3.24M 10-K · filed 2021-07-26 |
| 2019-01-31 | $3.31M 10-Q · filed 2020-03-16 |
| 2018-10-31 | $1.96M 10-Q · filed 2019-12-16 |
| 2018-07-31 | $1.17M 10-Q · filed 2019-09-16 |
| 2018-04-30 | $1.01M 10-K · filed 2020-07-28 |
| 2018-01-31 | $1.06M 10-Q · filed 2019-03-18 |
| 2017-10-31 | $660.00K 10-Q · filed 2018-12-17 |
| 2017-07-31 | $580.00K 10-Q · filed 2018-09-14 |
| 2017-04-30 | $3.44M 10-K · filed 2019-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |